Abstract
WE recently demonstrated that the molar pigmentary potency of human β-lipotropin (β-LPH) is greater than other melanocyte-stimulating hormones (MSHs) on Anolis skin; it is 2.6–4.0 times greater than α-MSH1 using the Anolis rate method of MSH bioassay2. We also found (unpublished) human β-LPH to be 2 to 4 times more potent than α-MSH using the steady state (quantal3) method. This was due to a potentiation of the MSH sequence of β-LPH (LPH47–53) by a factor associated with β-endorphin (LPH61–91). We showed that the melanotropin potentiating factor (MPF) was not the opiate peptide, 5Metenkephalin (LPH61–65)4, and now report the identification of MPF as the sequence LPH88–91.
Similar content being viewed by others
References
Carter, R. J. & Shuster, S. IRCS Medical Science 6, 453 (1978); J. Endocr. 80, 7P (1979).
Carter, R. J. & Shuster, S. J. Endocr. 77, 45P (1978); J. invest. Derm. 71, 229–232 (1978).
Tilders, F. J. H., van Delft, A. M. L. & Smelik, P. G. J. Endocr. 66, 165–175 (1975).
Hughes, J. Brain Res. 88, 795–808 (1975).
UK Patent Specification no. 1524319.
Shuster, S. & Thody, A. J. J. invest. Derm. 62, 172–190 (1974).
Rigter, H., Shuster, S. & Thody, A. J. J. Pharm. Pharmac. 29, 110–111 (1977).
Bliss, C. J. in Vitamin Methods (ed. Gyorgy, P.) 445–610 (Academic, New York, 1952).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CARTER, R., SHUSTER, S. & MORLEY, J. Melanotropin potentiating factor is the C-terminal tetrapeptide of human β-lipotropin. Nature 279, 74–75 (1979). https://doi.org/10.1038/279074a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/279074a0
- Springer Nature Limited
This article is cited by
-
β-endorphin binding in cultured adrenal cortical cells
Endocrine (1995)
-
Glycyl glutamine, an inhibitory neuropeptide derived from β-endorphin
Nature (1983)